Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Maintenance for drug dependence, opioid substitution treatment
Maintenance treatment bipolar disorder schizophrenia psychotic depression
major depressive disorder (MDD) 335-361 older people bipolar depression comparison
Management of adverse effects of hormone replacement therapy (HRT)
Management of antipsychotic-induced orthostatic hypotension
Management of QT prolongation in patients receiving antipsychotic drugs
Management with alternative substances
Managing treatment-resistant depression
Mania antipsychotic treatments lithium treatment treatment in children and adolescents valproate treatment acute/hypomania benzodiazepines people living with human immunodeficiency virus treatment strategies
Mania: suggested drug doses
Mania (bipolar disorder) benzodiazepines lithium treatment treatment options antipsychotics carbamazepine manic switch, depression in children and adolescents valproate treatment
Maximum dose
Mean cell haemoglobin concentration, psychotropic agent effects
Medical menopause, assessing premenstrual syndrome/premenstrual dysphoric disorder
Medication Adherence Rating Scale (MARS) 931
Melatonin adverse effects, children and adolescents description for antipsychotic-induced weight gain children and adolescents efficacy managing behavioural and psychological symptoms of dementia
Melatonin use for sleep disturbance/insomnia Autism spectrum disorder (ASD) in children and adolescents Melatonin in the treatment of insomnia in children and adolescents Bipolar disorder in children and adolescents
Memantine Alternatives to clozapine Optimising clozapine treatment alzheimerâ™s disease
Menopause diagnosis genitourinary symptoms and treatments increased adiposity effects psychological symptoms depression/anxiety elderly care hormone replacement therapy Menopause psychosis
Menopause symptoms
Mental Health Act (MHA), England and Wales (1983) 629 Management of inappropriate sexual behaviour in older adults Covert administration of medicines within food and drink The Mental Health Act in England and Wales
Mephadone, misuse and dependence Drug-induced excited state Stimulant use disorder (SUD) GHB and GBL dependence
Metabolism of alcohol.
Metformin possible mood improvement in type II diabetes for antipsychotic-induced weight gain
Methadone cautions hepatorenal dysfunction in overdose opioid substitution treatment titration schedules transition to buprenorphine buprenorphine comparison general hospital settings initiation of treatment intoxication psychiatric hospital settings transferring back from buprenorphine withdrawal
Methadone titration where extent of prior use is unknown or unconfirmed
Methamphetamine use disorder psychotic symptoms detoxification
Metreleptin, weight restoration in anorexia nervosa
Microdeletion syndromeq11.2 deletion syndrome,820-823
Mild alcohol withdrawal